AngioDynamics Says Rival Must Stay In $145M Damages Row

By David Matthews · September 19, 2018, 9:51 PM EDT

Medical device maker AngioDynamics Inc. pushed back Wednesday against a competitor's attempt to toss racketeering claims, arguing in Massachusetts federal court that the competitor is culpable in Biolitec AG's alleged scheme...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum in Opposition to Motion

Case Information

Case Title

AngioDynamics, Inc. v. Wolfgang Neuberger, et al.,

Case Number

Court

Massachusetts

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

March 15, 2018

Recent Articles By David

November 02, 2018
Ailing Home Health Care Fraudsters Get 1 Day In Prison
October 29, 2018
Chicago Insurance Exec Pleads Guilty To $13.5M Fraud
October 17, 2018
7th Circ. Upholds Conviction For Doc Who Ripped Off Insurers
October 10, 2018
Blue Cross Blue Shield Robs Chicago Taxpayers, Suit Says
October 02, 2018
Doctors Say Jury Doubled Up $4.4M Judgment, Seek New Trial
September 20, 2018
Data Breaches Caused No Harm, Health System Argues